According to Coherent Market Insights, DNA Sequencing Market is estimated to be valued at USD 8,486.7 Mn in 2025 and is expected to reach USD 18,412.4 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 11.7% from 2025 to 2032. The DNA Sequencing Market is witnessing robust growth, propelled by rising adoption in clinical diagnostics, personalized medicine, and biotechnology research. The increasing incidence of genetic disorders, cancer, and infectious diseases is further accelerating the demand for sequencing technologies, owing to their critical role in enabling early and precise detection.
Request Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/5531
Global DNA Sequencing Market Key Takeaways
Consumables are projected to remain a highly sought-after product type, accounting for 45.5% of the global DNA sequencing market share in 2025.
Next-generation sequencing remains the most widely used technology in the market.
As per CMI’s new DNA sequencing market analysis, oncology segment is expected to hold a prominent market share by the end of 2025.
North America, with an estimated market share of 37.8% in 2025, is projected to maintain its dominance over the global DNA sequencing industry.
Europe is slated to emerge as the most lucrative market for DNA sequencing companies during the assessment period.
Expanding Medical and Clinical Applications Spurring Market Growth
According to Coherent Market Insights (CMI), the DNA sequencing market outlook appears promising. This is mainly due to increasing use of DNA sequencing technologies in medical and clinical applications.
DNA sequencing is being widely used for many applications in healthcare. These include identifying genetic disorders, detecting microbial infection, guiding cancer treatment, and supporting personalized medicine. It is also used in areas such as prenatal testing and rare disease diagnosis.
Doctors and researchers rely on sequencing to better understand diseases and create targeted therapies. This growing use in hospitals, clinics, and research centers is expected to boost growth of the DNA sequencing market during the forecast period.
Immediate Delivery Available | Buy This Premium Research Report: https://www.coherentmarketinsights.com/insight/buy-now/5531
High Cost of DNA Sequencing Technologies Limiting Market Growth
Despite a strong growth trajectory, certain factors might slow down DNA sequencing market. High cost of DNA sequencing technologies is one such prominent factor.
Advanced sequencing platforms, consumables, and data analysis are still very expensive. This lowers their adoption in resource-constrained settings, thereby dampening overall DNA sequencing market demand.
Technological Advancements Unlocking Growth Opportunities
Innovations such as nanopore sequencing, single-cell sequencing, and AI-based bioinformatics are improving speed, accuracy, and accessibility of DNA sequencing. New sequencing platforms are being introduced that can process more samples simultaneously.
Top players are developing affordable benchtop sequencing devices to make DNA sequencing more accessible. For instance, Illumina recently introduced the MiSeq i100 Series of sequencing systems to make NSG accessible to more laboratories. These innovations are expected to create new revenue streams for the DNA sequencing market during the forthcoming period.
Also Read: DNA Sequencing Equipment and Services Market Outlook for 2025-2032
Emerging DNA Sequencing Market Trends
Declining cost of sequencing is emerging as a key growth-shaping trend in the DNA sequencing market. Sequencing costs have dropped significantly over the last few decades, thanks to next-generation sequencing, better chemistries, and improved reagents. For instance, since the advent of NSG technologies, the cost of sequencing a human genome has dropped from around $1 million in 2007 to just $600 in 2024. This is making sequencing accessible not just to big research centers but also to smaller labs, clinical settings, and areas where cost was a barrier, thereby fueling market growth.
Rising popularity of precision medicine and companion diagnostics is expected to boost demand for DNA sequencing technologies during the forecast period. This is because sequencing plays a key role in creating tailored therapies for diseases as well as enabling early disease detection.
Increasing research and development (R&D) activities will likely boost growth of the DNA sequencing market. More research in areas like genomics, transcriptomics, epigenomics, and microbiomics is increasing the need for sequencing tools and services. Similarly, there is a growing interest in global population genomic projects and rare disease studies. This is expected to boost sales of DNA sequencing products in the coming years.
DNA sequencing is also being used in industries like agriculture, environmental monitoring, and microbiome research. Growing demand from these sectors is slated to boost the DNA sequencing market value.
Use of artificial intelligence (AI) is also becoming popular in the DNA sequencing landscape. This advanced technology is being employed to analyze genomic data, detect mutations, and support faster, more accurate diagnoses.
Also Read: Next Generation Sequencing Market Size, Share, Trends & Opportunities for 2025-2032
Analyst’s View
“The global DNA sequencing industry is set to exhibit robust growth, owing to expanding medical and clinical applications, growing demand for precision medicine, increasing R&D activities, declining cost of sequencing, and ongoing technological advancements,” said a senior CMI analyst.
Current Events and Their Impact on the DNA Sequencing Market
|
Event |
Description and Impact |
|
Global Healthcare Infrastructure Digitization |
|
|
AI Integration and Computational Breakthroughs |
|
|
Long-Read Sequencing Technology Maturation |
|
Competitor Insights
Key companies listed in DNA sequencing market report:
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- PerkinElmer Genomics
- Agilent Technologies, Inc.
- Hoffmann-La Roche Ltd.
- QIAGEN
- Abbott
- Macrogen, Inc.
- PacBio
- Hamilton Company
- Zymo Research Corporation
- ZS Genetics, Inc.
- Tecan Trading AG
- LI-COR, Inc.
- Oxford Nanopore Technologies plc
Key Developments
· In February 2025, Roche unveiled a new type of next-generation sequencing called Sequencing by Expansion (SBX). This technology is designed to address the limitation of existing sequencing solutions. SBX uses expanded synthetic molecules to determine the DNA sequence of a target molecules.
· In October 2024, Illumina, Inc. launched the MiSeq i100 Series of sequencing systems. These systems are intended to make next-generation sequencing accessible to more labs.
· In May 2024, QIAGEN launched the QIAseq Multimodal DNA/RNA Library Kit. This new kit enables streamlined DNA and RNA library preparation for next-generation sequencing (NSG) from a single sample.
Request For Customization: https://www.coherentmarketinsights.com/insight/request-customization/5531
Market Segmentation
- Global DNA Sequencing Market, By Product Type
- Consumables
- Instruments
- Services
- Global DNA Sequencing Market, By Technology
- Sanger Sequencing
- Next-Generation Sequencing
- Third- Generation DNA Sequencing
- Others
- Global DNA Sequencing Market, By Application
- Oncology
- Reproductive Health
- Clinical Investigation
- Agrigenomics & Forensics
- Metagenomics, Epidemiology & Drug Development
- Others
- Global DNA Sequencing Market, By End User
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Clinical Research
- Others
- Global DNA Sequencing Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Also Read: Global Sanger Sequencing Market Analysis and Forecast for 2025-2032
Our Trusted Partners:
Worldwide Market Reports, Coherent MI, Stratagem Market Insights
Get Recent News:
https://www.coherentmarketinsights.com/news
About Us:
Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.
Contact Us:
Mr. Shah
Coherent Market Insights Pvt. Ltd,
U.S.: + 12524771362
U.K.: +442039578553
AUS: +61-8-7924-7805
INDIA: +91-848-285-0837
✉ Email: sales@coherentmarketinsights.com
